Literature DB >> 17709510

CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate.

Shaomin Tian1, Robert Maile, Edward J Collins, Jeffrey A Frelinger.   

Abstract

Binding of peptide/MHC (pMHC) complexes by TCR initiates T cell activation. Despite long interest, the exact relationship between the biochemistry of TCR/pMHC interaction (particularly TCR affinity or ligand off-rate) and T cell responses remains unresolved, because the number of complexes examined in each independent system has been too small to draw a definitive conclusion. To test the current models of T cell activation, we have analyzed the interactions between the mouse P14 TCR and a set of altered peptides based on the lymphocytic choriomeningitis virus epitope gp33-41 sequence bound to mouse class I MHC D(b). pMHC binding, TCR-binding characteristics, CD8+ T cell cytotoxicity, and IFN-gamma production were measured for the peptides. We found affinity correlated well with both cytotoxicity and IFN-gamma production. In contrast, no correlation was observed between any kinetic parameter of TCR-pMHC interaction and cytotoxicity or IFN-gamma production. This study strongly argues for an affinity threshold model of T cell activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17709510     DOI: 10.4049/jimmunol.179.5.2952

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  Fast on-rates allow short dwell time ligands to activate T cells.

Authors:  Christopher C Govern; Michelle K Paczosa; Arup K Chakraborty; Eric S Huseby
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

2.  T cell avidity and tumor immunity: problems and solutions.

Authors:  Arthur A Hurwitz; Steven M Cuss; Katherine E Stagliano; Ziqiang Zhu
Journal:  Cancer Microenviron       Date:  2013-12-20

3.  Kinetic proofreading and the search for nonself-peptides.

Authors:  Andreas Jansson
Journal:  Self Nonself       Date:  2011-01-01

4.  Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermia.

Authors:  Thomas A Mace; Lingwen Zhong; Casey Kilpatrick; Evan Zynda; Chen-Ting Lee; Maegan Capitano; Hans Minderman; Elizabeth A Repasky
Journal:  J Leukoc Biol       Date:  2011-08-26       Impact factor: 4.962

5.  TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.

Authors:  Mathilde Allard; Barbara Couturaud; Laura Carretero-Iglesia; Minh Ngoc Duong; Julien Schmidt; Gwennaëlle C Monnot; Pedro Romero; Daniel E Speiser; Michael Hebeisen; Nathalie Rufer
Journal:  JCI Insight       Date:  2017-07-20

Review 6.  To affinity and beyond: harnessing the T cell receptor for cancer immunotherapy.

Authors:  Jessica E Thaxton; Zihai Li
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  Estimating in vivo death rates of targets due to CD8 T-cell-mediated killing.

Authors:  Vitaly V Ganusov; Rob J De Boer
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

8.  A TCR affinity threshold regulates memory CD4 T cell differentiation following vaccination.

Authors:  Christina K Baumgartner; Hideo Yagita; Laurent P Malherbe
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

9.  A cell-based MHC stabilization assay for the detection of peptide binding to the canine classical class I molecule, DLA-88.

Authors:  Peter Ross; Jennifer C Holmes; Gregory S Gojanovich; Paul R Hess
Journal:  Vet Immunol Immunopathol       Date:  2012-09-21       Impact factor: 2.046

10.  Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice.

Authors:  Scott G Kitchen; Michael Bennett; Zoran Galić; Joanne Kim; Qing Xu; Alan Young; Alexis Lieberman; Aviva Joseph; Harris Goldstein; Hwee Ng; Otto Yang; Jerome A Zack
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.